Growing community of inventors

Cestas, France

Jean Ducassou

Average Co-Inventor Count = 3.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Jean Ducassou ↔ Roberto Carlos Bravo González (4 patents)Jean Ducassou ↔ Patrick Shannon (4 patents)Jean Ducassou ↔ Roberto Carlos Bravo Gonzalez (1 patent)Jean Ducassou ↔ Patrick Shannon (1 patent)Jean DucassouJean Ducassou (4 patents)Roberto Carlos Bravo GonzálezRoberto Carlos Bravo González (15 patents)Patrick ShannonPatrick Shannon (4 patents)Roberto Carlos Bravo GonzalezRoberto Carlos Bravo Gonzalez (1 patent)Patrick ShannonPatrick Shannon (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cancer Prevention Pharmaceuticals, Inc. (4 from 5 patents)


4 patents:

1. 12350246 - Eflornithine and sulindac, fixed dose combination formulation

2. 11925613 - Eflornithine and sulindac, fixed dose combination formulation

3. 11529326 - Eflornithine and sulindac, fixed dose combination formulation

4. 10973790 - Eflornithine and sulindac, fixed dose combination formulation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/20/2025
Loading…